Insider · CIK 0001779614

Lisicki Robert

Reports to the SEC for 3 companies · HENDERSON, NV

sec.gov

Transactions

Companies

Filings

CIK

0001779614

Forms 4 and 5

Insider transactions

46 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-02-27	ZURAZura Bio Ltd · Employee Share Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+1.15M sh	—	—	1,153,000
2025-01-23	CVKDCadrenal Therapeutics, Inc. · Stock OptionsA Award	Director	AAward	+20K sh	—	—	20,000
2024-12-09	ZURAZura Bio Ltd · Employee Share Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+117K sh	—	—	117,000
2024-06-18	ZURAZura Bio Ltd · Employee Share Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+1.05M sh	—	—	1,050,000
2024-01-24	ZURAZura Bio Ltd · Stock optionsA Award	Director, Chief Executive Officer	AAward	+1M sh	—	—	1,000,000
2024-01-18	CVKDCadrenal Therapeutics, Inc. · Stock OptionsA Award	Director	AAward	+50K sh	—	—	50,000
2023-07-23	CVKDCadrenal Therapeutics, Inc. · Stock optionsA Award	Director	AAward	+75K sh	—	—	75,000
2022-03-11	ARENA PHARMACEUTICALS INCJ Other	EVP, Chief Commercial Officer	JOther	−9,441 sh	—	—	28,122
2022-03-11	ARENA PHARMACEUTICALS INCJ Other	EVP, Chief Commercial Officer	JOther	−6,660 sh	—	—	21,462
2022-03-11	ARENA PHARMACEUTICALS INCJ Other	EVP, Chief Commercial Officer	JOther	−21.5K sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCEmployee Performance Restricted Stock UnitD Disposition to Issuer	EVP, Chief Commercial Officer	DDisposition to Issuer	−15.2K sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	EVP, Chief Commercial Officer	DDisposition to Issuer	−38.9K sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	EVP, Chief Commercial Officer	DDisposition to Issuer	−70K sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	EVP, Chief Commercial Officer	DDisposition to Issuer	−75K sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	EVP, Chief Commercial Officer	DDisposition to Issuer	−110K sh	—	—	0
2022-01-03	ARENA PHARMACEUTICALS INCA Award	EVP, Chief Commercial Officer	AAward	+21.5K sh	—	—	37,563
2021-08-03	ARENA PHARMACEUTICALS INCS Sale	EVP, Chief Commercial Officer	SSale	−5,605 sh	$59.84	−$335K	27,996
2021-08-03	ARENA PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+17.5K sh	$40.95	+$717K	33,601
2021-08-03	ARENA PHARMACEUTICALS INCS Sale	EVP, Chief Commercial Officer	SSale	−11.9K sh	$60.20	−$716K	16,101
2021-08-03	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−17.5K sh	—	—	110,000
2021-03-01	ARENA PHARMACEUTICALS INCEmployee Performance Restricted Stock UnitA Award	EVP, Chief Commercial Officer	AAward	+15.2K sh	—	—	15,200
2021-03-01	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)A Award	EVP, Chief Commercial Officer	AAward	+38.9K sh	—	—	38,850
2021-03-01	ARENA PHARMACEUTICALS INCA Award	EVP, Chief Commercial Officer	AAward	+6,660 sh	—	—	16,101
2021-02-02	ARENA PHARMACEUTICALS INCS Sale	EVP, Chief Commercial Officer	SSale	−9,359 sh	$79.35	−$743K	9,441
2021-02-02	ARENA PHARMACEUTICALS INCS Sale	EVP, Chief Commercial Officer	SSale	−6,400 sh	$78.50	−$502K	18,800
2021-02-02	ARENA PHARMACEUTICALS INCS Sale	EVP, Chief Commercial Officer	SSale	−1,741 sh	$77.70	−$135K	25,200
2021-02-02	ARENA PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+17.5K sh	$40.95	+$717K	26,941
2021-02-02	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−17.5K sh	—	—	127,500
2021-01-07	ARENA PHARMACEUTICALS INCF Tax Payment	EVP, Chief Commercial Officer	FTax Payment	−3,159 sh	$77.59	−$245K	9,441
2021-01-07	ARENA PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+12.6K sh	—	—	12,600
2021-01-07	ARENA PHARMACEUTICALS INCPerformance Restricted Stock UnitM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−12.6K sh	—	—	0
2020-12-01	ARENA PHARMACEUTICALS INCS Sale	EVP, Chief Commercial Officer	SSale	−300 sh	$64.87	−$19.5K	3,572
2020-12-01	ARENA PHARMACEUTICALS INCS Sale	EVP, Chief Commercial Officer	SSale	−3,022 sh	$66.06	−$200K	550
2020-12-01	ARENA PHARMACEUTICALS INCS Sale	EVP, Chief Commercial Officer	SSale	−550 sh	$66.72	−$36.7K	0
2020-11-25	ARENA PHARMACEUTICALS INCPerformance Restricted Stock UnitM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−6,300 sh	—	—	12,600
2020-11-25	ARENA PHARMACEUTICALS INCF Tax Payment	EVP, Chief Commercial Officer	FTax Payment	−2,428 sh	$65.50	−$159K	3,872
2020-11-25	ARENA PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+6,300 sh	—	—	6,300
2020-08-04	ARENA PHARMACEUTICALS INCS Sale	EVP, Chief Commercial Officer	SSale	−7,425 sh	$62.63	−$465K	22,575
2020-08-04	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−30K sh	—	—	115,000
2020-08-04	ARENA PHARMACEUTICALS INCS Sale	EVP, Chief Commercial Officer	SSale	−22.6K sh	$63.58	−$1.44M	0
2020-08-04	ARENA PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+30K sh	$40.95	+$1.23M	30,000
2020-03-01	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)A Award	EVP, Chief Commercial Officer	AAward	+70K sh	—	—	70,000
2019-11-13	ARENA PHARMACEUTICALS INCS Sale	EVP, Chief Commercial Officer	SSale	−4,429 sh	$45.83	−$203K	0
2019-10-14	ARENA PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+6,300 sh	—	—	6,300
2019-10-14	ARENA PHARMACEUTICALS INCF Tax Payment	EVP, Chief Commercial Officer	FTax Payment	−1,871 sh	$47.32	−$88.5K	4,429
2019-10-14	ARENA PHARMACEUTICALS INCPerformance Restricted Stock UnitM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−6,300 sh	—	—	18,900

Recent filings

Accepted (ET)
Mar 34
Lisicki Robert0001415889-25-006201
SEC(opens sec.gov)
Jan 244
Lisicki Robert0001213900-25-006628
SEC(opens sec.gov)
Dec 114
Lisicki Robert0001415889-24-028971
SEC(opens sec.gov)
Jun 214
Lisicki Robert0001415889-24-017861
SEC(opens sec.gov)
Jan 264
Lisicki Robert0001104659-24-007066
SEC(opens sec.gov)
Jan 194
Lisicki Robert0001213900-24-005002
SEC(opens sec.gov)
Jul 244
Lisicki Robert0001213900-23-059274
SEC(opens sec.gov)
Mar 114
Lisicki Robert0001628280-22-005884
SEC(opens sec.gov)
Jan 54
Lisicki Robert0001628280-22-000338
SEC(opens sec.gov)
Aug 54
Lisicki Robert0001628280-21-015950
SEC(opens sec.gov)

Companies

Address

C/O ZURA BIO LTD 1489 WEST WARM SPRINGS ROAD, #110

HENDERSON, NV, 89014